EMCDDA news

Changing dynamics in the heroin market, the latest implications of cannabis use and new features and dimensions of the stimulant and ‘new drugs’ scene are among the issues highlighted in the European Drug Report 2015: Trends and Developments. This years’ annual review reflects on 20 years of monitoring and examines the global influences and local ramifications of Europe’s ever-changing drugs problem.

This short report provides an overview of how European countries are developing innovative legal responses to the challenges presented to public health and drug policy by the rapidly evolving market for new psychoactive substances.

Illicit drug problems and responses and the different forms they can take in the city environment are explored in this paper. It addresses four areas: urban spaces and drug use, responses to city-level drug problems, city-level drugs strategies, and the coordination and funding of city-level policies.

The series ‘A year in review’ contains the essence of the EMCDDA's General Report of Activities. It is designed to provide interested audiences with a brief, four-page summary of the agency’s achievements for the year concerned with a focus on key topics.

The report describes trends in drug injection in the EU Member States, Norway and Turkey between 2000 and 2011, through an analysis of data on those admitted to drug treatment. Results indicate that current drug injection, including its incidence, has declined in recent years in Europe. While heroin remains the drug most frequently involved in drug injection, data show how drug injectors are now more likely to be using stimulants than in the past.

The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme. The report is a useful information source for all those seeking comprehensive information on the Centre and its work

The latest developments in monitoring and responding to new psychoactive substances (NPS/’new drugs’) were discussed at the 15th annual meeting of the Reitox Early Warning System (EWS) network, held in Lisbon from 8–9 June.

Changing dynamics in the heroin market, the latest implications of cannabis use and new features and dimensions of the stimulant and ‘new drugs’ scene, are among the issues highlighted by the EU drugs agency (EMCDDA) today as it launches its European Drug Report 2015: Trends and Developments in Lisbon. In its annual review, the agency reflects on 20 years of monitoring and examines the global influences and local ramifications of Europe’s ever-changing drugs problem.

This brochure provides an overview of the 2015 European Drug Report package and includes brief summaries of the four new additions to the Perspectives on drugs (PODs) series.

Changing dynamics in the heroin market, the latest implications of cannabis use and new features and dimensions of the stimulant and ‘new drugs’ scene are among the issues highlighted in the European Drug Report 2015: Trends and Developments. This years’ annual review reflects on 20 years of monitoring and examines the global influences and local ramifications of Europe’s ever-changing drugs problem.